Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape
Sarah McNamee, Neşe Devenot, Meaghan Buisson
JAMA Psychiatry (2023) Vol. 80, Iss. 5, pp. 411-411
Closed Access | Times Cited: 112

Showing 26-50 of 112 citing articles:

Psilocybin history, action and reaction: A narrative clinical review
Pravesh Sharma, Quang A. Nguyen, Sadie J. Matthews, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 9, pp. 849-865
Closed Access | Times Cited: 13
Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs
Oliver Robinson, Jules Evans, David Luke, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 5
Experiential Training in Psychedelic‐Assisted Therapy: A Risk‐Benefit Analysis
Daniel Rosenbaum, Crystal Hare, Emma Hapke, et al.
The Hastings Center Report (2024) Vol. 54, Iss. 4, pp. 32-46
Open Access | Times Cited: 5
The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD
Kelley C. O’Donnell, Lauren Okano, Michael Alpert, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 5
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Blerida Banushi, Vince Polito
Biology (2023) Vol. 12, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 12
Adverse Events Should Not Be Surprising in Psychedelic Research
Rebecca Ehrenkranz, Manish Agrawal, Sandeep M. Nayak, et al.
Psychedelic Medicine (2024)
Closed Access | Times Cited: 4
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases
Sivan Schipper, Kabir Nigam, Yasmin Schmid, et al.
Cochrane library (2024) Vol. 2024, Iss. 9
Closed Access | Times Cited: 4
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access
Relationality and Ethics in MDMA-Assisted Therapy
Jamie Beachy, Willa Hall, Chantelle Thomas, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 67-71
Open Access
From Safe Touch to Sexual Abuse: Walking the Tightrope of Patient Safety in Psychedelic Therapy
Y. Tony Yang
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 123-125
Closed Access
Focused Bodywork as Facilitated Communication: Cautionary Perspectives on Touch in Psychedelic Therapy
Neşe Devenot
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 61-64
Closed Access
Psychedelics as moral bioenhancers: Protocol for a scoping review of ethical arguments for and against
S L Streicher, Christopher Register, Xiu Lim, et al.
Wellcome Open Research (2025) Vol. 10, pp. 3-3
Open Access
On Minimizing Risk and Harm in the Use of Psychedelics
Jules Evans, Marc Aixalà, B. Anderson, et al.
Psychiatric Research and Clinical Practice (2025) Vol. 7, Iss. 1, pp. 4-8
Open Access
Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
Nadine Loh, David Luke
Psychoactives (2025) Vol. 4, Iss. 1, pp. 7-7
Open Access
Side Effects of Microdosing Lysergic Acid Diethylamide and Psilocybin: A Systematic Review of Potential Physiological and Psychiatric Outcomes
Stefan Modzelewski, Anna Stankiewicz, Napoleon Waszkiewicz, et al.
Neuropharmacology (2025), pp. 110402-110402
Closed Access
Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics: A Mixed-Methods Investigation
Daniel J. Kruger, Eirini K. Argyri, Justin K. Mogilski, et al.
The Journal of Sex Research (2025), pp. 1-12
Closed Access
Enhanced independence: De-biasing processes in psychedelic research and beyond
Katherine Cheung, Rebecca Ehrenkranz, David B. Yaden
Research Ethics (2025)
Open Access
Mitigating Ethical Issues in Training for Psychedelic Therapy
Christopher Poppe, Daniel Villiger, Dimitris Repantis, et al.
Neuroethics (2025) Vol. 18, Iss. 1
Open Access
Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement
Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e095992-e095992
Open Access
From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence‐Based Policy and Practice
Eduardo Ekman Schenberg
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 2
Open Access
Clarifying the Concept of Psychological Support in Psychedelic Clinical Trials
Jonathan Schettino, Katherine Cheung, Sandeep M. Nayak, et al.
(2025)
Closed Access
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
Samuli Kangaslampi, Josjan Zijlmans
European Child & Adolescent Psychiatry (2023)
Open Access | Times Cited: 9
Getting in Touch with Touch: The Importance of Studying Touch in MDMA-Assisted Therapy and the Development of a New Self-Report Measure
Jason B. Luoma, Luke R. Allen, Veronika Gold, et al.
Psychedelic Medicine (2024) Vol. 2, Iss. 1, pp. 25-32
Open Access | Times Cited: 3
Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics
Daniel Z. Buchman, Daniel Rosenbaum
Public Health Ethics (2024) Vol. 17, Iss. 1-2, pp. 24-39
Open Access | Times Cited: 3

Scroll to top